Skip to content

What is Zepbound? Uses, cost, doses and side effects

By the glp1doses editorial team
Every number is checked against FDA labels and official price pages. How we check

The short answer

Zepbound (tirzepatide) is a once-weekly injection made by Eli Lilly. It's approved for long-term weight reduction in adults with obesity, or overweight with a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity. The lowest self-pay price is $299 a month for the 2.5 mg starting dose through LillyDirect.

Source: LillyDirect self-pay

Key takeaways

  • Zepbound has two approved uses in adults: weight reduction, and moderate to severe obstructive sleep apnea with obesity.
  • Paying cash? LillyDirect vials and the KwikPen run from $299 to $449 a month, depending on your dose.
  • On 7.5 mg or higher through LillyDirect, refill within 45 days of getting your last fill or you pay the higher regular price.
  • Missed a dose? If it's been 4 days or less, take it as soon as possible. Otherwise, skip it.
  • Don't use Zepbound if you or a family member has had medullary thyroid carcinoma (MTC), or if you have MEN 2.

Zepbound at a glance

Zepbound facts from the FDA label and verified prices
Active ingredienttirzepatide
MakerEli Lilly and Company
FDA-approved uses
  • reduce excess body weight and maintain weight reduction long term in adults with obesity, or overweight with at least one weight-related comorbid condition
  • moderate to severe obstructive sleep apnea (OSA) in adults with obesity
Forms and strengths
  • KwikPen (multi-dose, 4 weekly doses): 2.5, 5, 7.5, 10, 12.5, 15 mg
  • Multi-dose vial (4 weekly doses): 2.5, 5, 7.5, 10, 12.5, 15 mg
  • Single-dose pen: 2.5, 5, 7.5, 10, 12.5, 15 mg
  • Single-dose vial: 2.5, 5, 7.5, 10, 12.5, 15 mg
Medicare GLP-1 BridgeCovered forms: KwikPen (multi-dose, 4 weekly doses)
Cheapest verified self-pay$449 per fill at 15 mg, LillyDirect self-pay (lilly.com)
With commercial insurance that covers it$25 per fill at 15 mg, Manufacturer savings card (commercial insurance, drug covered) (zepbound.lilly.com)
On Medicare Part D$50 per fill at 15 mg, Medicare GLP-1 Bridge (medicare.gov)
LabelRevised: 8/2026 (DailyMed version 40)

Zepbound dose schedule from the label

Put it on a calendar with the titration schedule builder. Only your prescriber decides when, and whether, your dose changes.

See every price

Every verified Zepbound price

Zepbound: price by where you buy, form and dose
Where you buyForm · dosePriceConditionsSource
Medicare GLP-1 BridgeKwikPen (multi-dose, 4 weekly doses) · All strengths$50/month
Conditions

Medicare GLP-1 Bridge demonstration, July 1, 2026 through December 31, 2027. For adults 18 or older with Medicare Part D drug coverage (standalone PDP, MA-PD, SNP, EGWP or LI NET) who meet the BMI criteria when starting GLP-1 therapy (BMI 35+, or BMI 30+ with diastolic heart failure, uncontrolled hypertension or CKD stage 3a+, or BMI 27+ with prediabetes, prior heart attack or stroke, or symptomatic peripheral artery disease). Not for people already getting GLP-1s through their Part D plan, or using the drug for type 2 diabetes, sleep apnea or fatty liver disease. Prior authorization required (valid through December 31, 2027 unless you change drugs). $50 copay per one-month supply (28 or 30 days); it does not count toward the Part D deductible or out-of-pocket limit and cannot be reduced by Extra Help. Zepbound is covered as the KwikPen only, prescribed for weight management; single-dose vials and pens are not covered. Pen needles are sold separately.

medicare.gov
Manufacturer savings cardcommercial insurance, drug not coveredKwikPen (multi-dose, 4 weekly doses) · 2.5 mg$299/month
Conditions

Commercial drug insurance that does not cover the Zepbound KwikPen; government beneficiaries excluded. Pay as low as $299 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $215. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardself-pay, no insuranceKwikPen (multi-dose, 4 weekly doses) · 2.5 mg$299/month
Conditions

Zepbound KwikPen Self-Pay Savings Card for cash-paying patients with no insurance used; you may not seek reimbursement from any insurer or apply the cost to a deductible. Pay as low as $299 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $215. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredKwikPen (multi-dose, 4 weekly doses) · 5 mg$399/month
Conditions

Commercial drug insurance that does not cover the Zepbound KwikPen; government beneficiaries excluded. Pay as low as $399 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $115. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardself-pay, no insuranceKwikPen (multi-dose, 4 weekly doses) · 5 mg$399/month
Conditions

Zepbound KwikPen Self-Pay Savings Card for cash-paying patients with no insurance used; you may not seek reimbursement from any insurer or apply the cost to a deductible. Pay as low as $399 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $115. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredKwikPen (multi-dose, 4 weekly doses) · 7.5 mg$449/month
Conditions

Commercial drug insurance that does not cover the Zepbound KwikPen; government beneficiaries excluded. Pay as low as $449 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $65. The $449 price applies to your first fill and to refills purchased within 45 days of the delivery/receipt of the previous fill; otherwise the regular price of $499 applies. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardself-pay, no insuranceKwikPen (multi-dose, 4 weekly doses) · 7.5 mg$449/month
Conditions

Zepbound KwikPen Self-Pay Savings Card for cash-paying patients with no insurance used; you may not seek reimbursement from any insurer or apply the cost to a deductible. Pay as low as $449 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $65. The $449 price applies to your first fill and to refills purchased within 45 days of the delivery/receipt of the previous fill; otherwise the regular price of $499 applies. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredKwikPen (multi-dose, 4 weekly doses) · 10 mg$449/month
Conditions

Commercial drug insurance that does not cover the Zepbound KwikPen; government beneficiaries excluded. Pay as low as $449 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $271. The $449 price applies to your first fill and to refills purchased within 45 days of the delivery/receipt of the previous fill; otherwise the regular price of $699 applies. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardself-pay, no insuranceKwikPen (multi-dose, 4 weekly doses) · 10 mg$449/month
Conditions

Zepbound KwikPen Self-Pay Savings Card for cash-paying patients with no insurance used; you may not seek reimbursement from any insurer or apply the cost to a deductible. Pay as low as $449 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $271. The $449 price applies to your first fill and to refills purchased within 45 days of the delivery/receipt of the previous fill; otherwise the regular price of $699 applies. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredKwikPen (multi-dose, 4 weekly doses) · 12.5 mg$449/month
Conditions

Commercial drug insurance that does not cover the Zepbound KwikPen; government beneficiaries excluded. Pay as low as $449 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $271. The $449 price applies to your first fill and to refills purchased within 45 days of the delivery/receipt of the previous fill; otherwise the regular price of $699 applies. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardself-pay, no insuranceKwikPen (multi-dose, 4 weekly doses) · 12.5 mg$449/month
Conditions

Zepbound KwikPen Self-Pay Savings Card for cash-paying patients with no insurance used; you may not seek reimbursement from any insurer or apply the cost to a deductible. Pay as low as $449 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $271. The $449 price applies to your first fill and to refills purchased within 45 days of the delivery/receipt of the previous fill; otherwise the regular price of $699 applies. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredKwikPen (multi-dose, 4 weekly doses) · 15 mg$449/month
Conditions

Commercial drug insurance that does not cover the Zepbound KwikPen; government beneficiaries excluded. Pay as low as $449 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $271. The $449 price applies to your first fill and to refills purchased within 45 days of the delivery/receipt of the previous fill; otherwise the regular price of $699 applies. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardself-pay, no insuranceKwikPen (multi-dose, 4 weekly doses) · 15 mg$449/month
Conditions

Zepbound KwikPen Self-Pay Savings Card for cash-paying patients with no insurance used; you may not seek reimbursement from any insurer or apply the cost to a deductible. Pay as low as $449 for a 1-month fill (28 days, 1 KwikPen), maximum monthly savings $271. The $449 price applies to your first fill and to refills purchased within 45 days of the delivery/receipt of the previous fill; otherwise the regular price of $699 applies. Up to 11 fills per calendar year. Card expires 12/31/2026. Pen needles sold separately.

zepbound.lilly.com
Manufacturer savings cardcommercial insurance, drug coveredSingle-dose pen · All strengths$25/month
Conditions

Commercial drug insurance that covers the Zepbound single-dose pen. Pay as little as $25 for a 1-, 2- or 3-month fill; maximum savings $100 per 1-month, $200 per 2-month or $300 per 3-month fill, and $1,300 per calendar year; up to 13 fills per year. Month is 28 days and up to 4 pens. Government beneficiaries (Medicare, Medicaid, TRICARE, VA etc.) excluded. Card expires 12/31/2026.

zepbound.lilly.com
Manufacturer savings cardcommercial insurance, drug not coveredSingle-dose pen · All strengths$499/month
Conditions

Commercial drug insurance that does not cover the Zepbound single-dose pen. Pay as low as $499 per 1-month fill (28 days, up to 4 pens); maximum monthly savings is the wholesale acquisition cost minus $499; up to 13 fills per calendar year. Government beneficiaries excluded. Card expires 12/31/2026.

zepbound.lilly.com
TrumpRxSingle-dose vial · 2.5 mg$299/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov; orders are fulfilled through LillyDirect, which confirms eligibility. TrumpRx lists the original (list) price as $1,087.00. Terms and conditions are Lilly's self-pay terms.

trumprx.gov
TrumpRxSingle-dose vial · 5 mg$399/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov; orders are fulfilled through LillyDirect, which confirms eligibility. TrumpRx lists the original (list) price as $1,087.00. Terms and conditions are Lilly's self-pay terms.

trumprx.gov
TrumpRxSingle-dose vial · 7.5 mg$449/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov; orders are fulfilled through LillyDirect, which confirms eligibility. Price applies to your first fill at this dose or refills within 45 days of the prior delivery/receipt; refills more than 45 days later cost $499. TrumpRx lists the original (list) price as $1,087.00. Terms and conditions are Lilly's self-pay terms.

trumprx.gov
TrumpRxSingle-dose vial · 10 mg$449/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov; orders are fulfilled through LillyDirect, which confirms eligibility. Price applies to your first fill at this dose or refills within 45 days of the prior delivery/receipt; refills more than 45 days later cost $699. TrumpRx lists the original (list) price as $1,087.00. Terms and conditions are Lilly's self-pay terms.

trumprx.gov
TrumpRxSingle-dose vial · 12.5 mg$449/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov; orders are fulfilled through LillyDirect, which confirms eligibility. Price applies to your first fill at this dose or refills within 45 days of the prior delivery/receipt; refills more than 45 days later cost $699. TrumpRx lists the original (list) price as $1,087.00. Terms and conditions are Lilly's self-pay terms.

trumprx.gov
TrumpRxSingle-dose vial · 15 mg$449/month
Conditions

Out-of-pocket (self-pay) price listed on TrumpRx.gov; orders are fulfilled through LillyDirect, which confirms eligibility. Price applies to your first fill at this dose or refills within 45 days of the prior delivery/receipt; refills more than 45 days later cost $699. TrumpRx lists the original (list) price as $1,087.00. Terms and conditions are Lilly's self-pay terms.

trumprx.gov
LillyDirect self-payKwikPen (multi-dose, 4 weekly doses) · 2.5 mg$299/month
Conditions

Self-pay only through LillyDirect (no insurance used). Month is 28 days and 1 single-patient-use KwikPen. Pen needle purchase required. 2.5 mg is a starting dose and is not approved as a maintenance dose. Program is not insurance; Lilly may change or end it at any time.

lilly.com
LillyDirect self-payKwikPen (multi-dose, 4 weekly doses) · 5 mg$399/month
Conditions

Self-pay only through LillyDirect (no insurance used). Month is 28 days and 1 single-patient-use KwikPen. Pen needle purchase required. Program is not insurance; Lilly may change or end it at any time.

lilly.com
LillyDirect self-payKwikPen (multi-dose, 4 weekly doses) · 7.5 mg$449/month
Conditions

Self-pay only through LillyDirect (no insurance used). Zepbound Journey Program price: applies to your first fill at this dose and to refills purchased within 45 days of the delivery/receipt of the previous fill. If the refill is more than 45 days late the regular price of $499 per month applies. Month is 28 days and 1 single-patient-use KwikPen. Pen needle purchase required. Program is not insurance; Lilly may change or end it at any time.

lilly.com
LillyDirect self-payKwikPen (multi-dose, 4 weekly doses) · 10 mg$449/month
Conditions

Self-pay only through LillyDirect (no insurance used). Zepbound Journey Program price: applies to your first fill at this dose and to refills purchased within 45 days of the delivery/receipt of the previous fill. If the refill is more than 45 days late the regular price of $699 per month applies. Month is 28 days and 1 single-patient-use KwikPen. Pen needle purchase required. Program is not insurance; Lilly may change or end it at any time.

lilly.com
LillyDirect self-payKwikPen (multi-dose, 4 weekly doses) · 12.5 mg$449/month
Conditions

Self-pay only through LillyDirect (no insurance used). Zepbound Journey Program price: applies to your first fill at this dose and to refills purchased within 45 days of the delivery/receipt of the previous fill. If the refill is more than 45 days late the regular price of $699 per month applies. Month is 28 days and 1 single-patient-use KwikPen. Pen needle purchase required. Program is not insurance; Lilly may change or end it at any time.

lilly.com
LillyDirect self-payKwikPen (multi-dose, 4 weekly doses) · 15 mg$449/month
Conditions

Self-pay only through LillyDirect (no insurance used). Zepbound Journey Program price: applies to your first fill at this dose and to refills purchased within 45 days of the delivery/receipt of the previous fill. If the refill is more than 45 days late the regular price of $699 per month applies. Month is 28 days and 1 single-patient-use KwikPen. Pen needle purchase required. Program is not insurance; Lilly may change or end it at any time.

lilly.com
LillyDirect self-paySingle-dose vial · 2.5 mg$299/month
Conditions

Self-pay only through LillyDirect (no insurance used). Month is 28 days and 4 single-dose vials. Needle and syringe purchase required. 2.5 mg is a starting dose and is not approved as a maintenance dose. Program is not insurance; Lilly may change or end it at any time.

lilly.com
LillyDirect self-paySingle-dose vial · 5 mg$399/month
Conditions

Self-pay only through LillyDirect (no insurance used). Month is 28 days and 4 single-dose vials. Needle and syringe purchase required. Program is not insurance; Lilly may change or end it at any time.

lilly.com
LillyDirect self-paySingle-dose vial · 7.5 mg$449/month
Conditions

Self-pay only through LillyDirect (no insurance used). Zepbound Journey Program price: applies to your first fill at this dose and to refills purchased within 45 days of the delivery/receipt of the previous fill. If the refill is more than 45 days late the regular price of $499 per month applies. Month is 28 days and 4 single-dose vials. Needle and syringe purchase required. Program is not insurance; Lilly may change or end it at any time.

lilly.com
LillyDirect self-paySingle-dose vial · 10 mg$449/month
Conditions

Self-pay only through LillyDirect (no insurance used). Zepbound Journey Program price: applies to your first fill at this dose and to refills purchased within 45 days of the delivery/receipt of the previous fill. If the refill is more than 45 days late the regular price of $699 per month applies. Month is 28 days and 4 single-dose vials. Needle and syringe purchase required. Program is not insurance; Lilly may change or end it at any time.

lilly.com
LillyDirect self-paySingle-dose vial · 12.5 mg$449/month
Conditions

Self-pay only through LillyDirect (no insurance used). Zepbound Journey Program price: applies to your first fill at this dose and to refills purchased within 45 days of the delivery/receipt of the previous fill. If the refill is more than 45 days late the regular price of $699 per month applies. Month is 28 days and 4 single-dose vials. Needle and syringe purchase required. Program is not insurance; Lilly may change or end it at any time.

lilly.com
LillyDirect self-paySingle-dose vial · 15 mg$449/month
Conditions

Self-pay only through LillyDirect (no insurance used). Zepbound Journey Program price: applies to your first fill at this dose and to refills purchased within 45 days of the delivery/receipt of the previous fill. If the refill is more than 45 days late the regular price of $699 per month applies. Month is 28 days and 4 single-dose vials. Needle and syringe purchase required. Program is not insurance; Lilly may change or end it at any time.

lilly.com
Hims & HersKwikPen (multi-dose, 4 weekly doses) · All strengths$299/month
Conditions

'From' price; medication only. Requires Hims Weight Loss Membership ($39 first month, then $149/month), billed separately. Cash-pay; insurance not required. Not available in all 50 states.

hims.com
RoKwikPen (multi-dose, 4 weekly doses) · 2.5 mg$299/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx.

ro.co
RoKwikPen (multi-dose, 4 weekly doses) · 5 mg$399/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx.

ro.co
RoKwikPen (multi-dose, 4 weekly doses) · 7.5 mg$449/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. 'With offer' price under a manufacturer offer for 7.5 mg and higher doses (Save $50).

ro.co
RoKwikPen (multi-dose, 4 weekly doses) · 10 mg$449/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. 'With offer' price under a manufacturer offer for 7.5 mg and higher doses (Save $150).

ro.co
RoKwikPen (multi-dose, 4 weekly doses) · 12.5 mg$449/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. 'With offer' price under a manufacturer offer for 7.5 mg and higher doses (Save $150).

ro.co
RoKwikPen (multi-dose, 4 weekly doses) · 15 mg$449/month
Conditions

Plus Ro Body membership ($39 first month, then $149/mo monthly or $74/mo prepaid annually). Cash-pay; Ro states prices match LillyDirect, NovoCare and TrumpRx. 'With offer' price under a manufacturer offer for 7.5 mg and higher doses (Save $150).

ro.co
MeasuredSingle-dose pen · All strengths$299/month
Conditions

Low end of the range shown; medication priced separately from membership (homepage 'Membership from $49/mo'; Zepbound page shows $99/mo). Range $299-$449/mo, covered by insurance or cash pay; sent to patient's pharmacy.

trymeasured.com
EdenSingle-dose pen · All strengths$1,399/month
Conditions

Same price at every dose. Medication only; requires Eden Membership ($39 first month, auto-renews at $99/month). Cash-pay; Eden does not take insurance. Page describes 'pre-measured auto-injector pens'.

eden.health
Hims & HersSingle-dose pen · All strengths$1,899/month
Conditions

Medication only. Requires Hims Weight Loss Membership ($39 first month, then $149/month), billed separately. Cash-pay; insurance not required. Not available in all 50 states.

hims.com
Hims & HersSingle-dose vial · All strengths$299/month
Conditions

'From' price; medication only. Requires Hims Weight Loss Membership ($39 first month, then $149/month), billed separately. Cash-pay; insurance not required. Not available in all 50 states.

hims.com
LifeMDSingle-dose vial · All strengths$299/month
Conditions

'Starting at' price, cash-pay. Plus LifeMD program fee ($39 first month, then $149/month). With insurance the page advertises copays as low as $25.

lifemd.com
Mochi HealthSingle-dose vial · All strengths$299/month
Conditions

'As low as' price; plus Mochi Health membership ($79/month, first month $0 promo for new subscribers). Medication not included in membership; availability and pricing vary by state. Doses 2.5-15 mg listed.

joinmochi.com
List priceSingle-dose pen · All strengths$1,086.37/fill
Conditions

Lilly publishes the Zepbound list price (WAC) as a range of $499 to $1,086.37 per fill without mapping each figure to a presentation; the top of the range is shown here for the single-dose pen. A monthly supply is 28 days.

pricinginfo.lilly.com

Zepbound is Eli Lilly’s brand of tirzepatide for weight management. It’s a prescription injection you take once a week. It’s also one of the most searched medicines in the United States, because the answers to basic questions (what it costs, which form to get, whether insurance pays) depend so much on your situation. This guide brings together what the FDA label says and what the manufacturer’s and the government’s own price pages show. Every clinical statement comes from the FDA label (Revised: 8/2026 (DailyMed version 40)).

What is Zepbound approved for?

Zepbound has two approved uses in adults:

  • Weight reduction and long-term maintenance in adults with obesity, or with overweight and at least one weight-related condition.
  • Moderate to severe obstructive sleep apnea (OSA) in adults with obesity.

For both uses, the label says to use Zepbound together with a reduced-calorie diet and increased physical activity.

The label also sets limits. Zepbound contains tirzepatide, so using it with another tirzepatide product or with any GLP-1 receptor agonist isn’t recommended. Its safety and effectiveness haven’t been established in children. It isn’t recommended for people with severe gastroparesis (very slow stomach emptying).

Zepbound and Mounjaro both contain tirzepatide and come from the same company, but their labels cover different uses. Mounjaro’s is for type 2 diabetes. A prescription is written for one brand or the other, and insurers treat them as separate drugs.

How well does Zepbound work for weight loss?

The label’s two main weight trials measured body weight after 72 weeks of treatment, with at least 52 weeks at the maintenance dose. Everyone in the trials, including the placebo group, also followed a reduced-calorie diet and increased physical activity.

  • Study 1 (adults without diabetes): mean (average) body weight changed by -15.0% at 5 mg, -19.5% at 10 mg and -20.9% at 15 mg, versus -3.1% with placebo.
  • Study 2 (adults with type 2 diabetes): the change was -12.8% at 10 mg and -14.7% at 15 mg, versus -3.2% with placebo.

These are averages across a trial group. Individual results vary, and the trials weren’t designed to tell you what your own result will be.

Zepbound for sleep apnea

For OSA, the label recommends a maintenance dose of 10 mg or 15 mg once weekly. The 5 mg dose is a maintenance dose for weight reduction only. In the label’s two 52-week sleep apnea studies, body weight changed by -17.7% (Study 5) and -19.6% (Study 6) with Zepbound, versus -1.6% and -2.3% with placebo. The label also reports breathing measures from those studies.

This approval matters for coverage as much as for treatment, because it’s a use Medicare Part D can pay for (see the Medicare section below).

What forms does Zepbound come in: vial, KwikPen or pen?

The label lists four forms, all in the same six strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg):

  • Single-dose pen. A prefilled pen that delivers one dose, then gets thrown away. A carton holds four pens, a 28-day supply. This is the form commercial insurance usually pays for, and the form the covered-insurance savings card applies to.
  • Single-dose vial. One dose per vial, drawn up with a syringe and needle that you buy separately. The label says to use a syringe that can measure the dose (for example a 1 mL syringe) and a new syringe and needle for each injection. Vials are sold only through LillyDirect self-pay.
  • KwikPen. One pen that holds four weekly doses. You attach a new pen needle each time and throw the pen away after the fourth dose, even if there’s medicine left in it. The label says the KwikPen isn’t recommended for self-administration by people who are visually impaired. It also says a KwikPen must never be shared between patients, even with a new needle.
  • Multi-dose vial. Also listed on the label, with four weekly doses per vial.

The label asks prescribers to tell you which form you’ll get and to make sure you’re trained on it, including if it changes later. A healthcare provider should show you how to prepare and inject before your first dose.

Vial vs KwikPen: which is cheaper?

Neither. Through LillyDirect, the single-dose vial and the KwikPen have the same self-pay price at every strength. The real differences are practical. The vial needs a syringe and a steady hand to draw up the dose. The KwikPen needs pen needles, and it’s the only form the Medicare GLP-1 Bridge covers. The pen vs vial vs pill comparer puts the forms side by side for any dose.

How much does Zepbound cost?

What you pay depends on how you pay:

  • Self-pay through LillyDirect (vial or KwikPen): $299 a month for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg, 10 mg, 12.5 mg and 15 mg.
  • Commercial insurance that covers Zepbound, with the savings card: as little as $25 per fill of the single-dose pen.
  • Commercial insurance that doesn’t cover it, with the savings card: $499 a month for the single-dose pen.
  • Medicare GLP-1 Bridge: a $50 monthly copay for the KwikPen, if you qualify.
  • List price: $1,086.37 per fill for the single-dose pen. This is the full price before any discount, and few people pay it directly.

The table on this page shows every price with its source. Our Zepbound cost guide explains each route, including what a full year adds up to, and the cost calculator will price your own dose path.

LillyDirect and the 45-day refill rule

LillyDirect is Lilly’s direct-to-patient pharmacy. Your prescriber sends the prescription there, and a partner pharmacy fills it for delivery or pickup. The self-pay prices are for people who don’t use insurance for the purchase, and you can’t claim reimbursement afterward.

The price for 7.5 mg and above is a program price. You get it on your first fill at that dose and on each refill you buy within 45 days of getting the last one. Refill later and the regular price applies: $499 for 7.5 mg and $699 for 10 mg, 12.5 mg and 15 mg. The 2.5 mg and 5 mg prices don’t have this rule. The 45-day refill rule page explains the timing in full, and the supply tracker shows your last on-time refill date.

TrumpRx lists the same vial prices and sends you to LillyDirect to buy. It’s a price-listing site, not a pharmacy. See how TrumpRx works.

The Zepbound savings card

Lilly’s savings card is for people with commercial (private or employer) drug insurance. If you’re enrolled in Medicare, Medicaid, TRICARE, VA or another government program, you can’t use it.

  • If your plan covers Zepbound, the card lowers a fill of the single-dose pen to as little as $25. Lilly caps how much it pays per fill and per calendar year, so a plan with a large deductible can leave you paying more than the headline figure.
  • If your plan doesn’t cover Zepbound, a separate offer sets the single-dose pen at $499 a month. A KwikPen version of the not-covered offer is priced by dose: $299, $399 and $449 for 7.5 mg and up, with the same refill window on the higher doses.
  • A self-pay card gives cash patients the same KwikPen prices at pharmacies outside LillyDirect.

You need to activate the cards, you can’t combine them with other offers, and they expire on 12/31/2026. Our savings card guide compares the manufacturer cards across drugs.

Telehealth programs

Several telehealth providers prescribe brand-name Zepbound and pass through the manufacturer’s price, then bill a membership on top. Ro, for example, lists the KwikPen at $299 for 2.5 mg, the same as LillyDirect, plus a membership of $149 a month after the first month. Our tables add the membership to the medicine price, so you’re comparing like with like.

What doses does Zepbound come in?

Zepbound comes in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, each injected once weekly. The label’s schedule is:

  1. Start at 2.5 mg once weekly for 4 weeks. This dose is for starting treatment and isn’t approved as a maintenance dose (the dose you stay on).
  2. Increase to 5 mg once weekly.
  3. Further increases, if needed, in 2.5 mg steps after at least 4 weeks on the current dose.

For weight reduction, the recommended maintenance dose is 5 mg, 10 mg or 15 mg. For sleep apnea, it’s 10 mg or 15 mg. The maximum for all uses is 15 mg once weekly. The 7.5 mg and 12.5 mg strengths are steps on the way up.

How fast you move up, and where you stop, is your prescriber’s decision, based on how you respond and what you tolerate. The dose ladder above shows each step, and the titration schedule tool turns it into dated steps.

How do you take Zepbound?

The label says to inject Zepbound under the skin of your abdomen or thigh. Another person can inject it in the back of your upper arm. Rotate the site with each dose. You can take it at any time of day, with or without meals.

What if I miss a dose of Zepbound?

The label gives a 4-day rule:

  • If 4 days (96 hours) or less have passed since the dose was due, take it as soon as possible.
  • If more than 4 days have passed, skip the missed dose and take the next dose on your regularly scheduled day.

Either way, you then go back to your regular weekly schedule. The label also lets you change your weekly day, as long as there are at least 3 days (72 hours) between two doses.

The missed dose tool applies these rules to your own dates. The label doesn’t give patients a rule for restarting after several missed doses in a row, so ask your prescriber. A long gap can also cost you money: on 7.5 mg and above, a late refill loses the LillyDirect program price.

What are the side effects of Zepbound?

Stomach and bowel effects are the most common. In the label’s pooled weight trials (Study 1 and Study 2, up to 72 weeks), gastrointestinal reactions were reported by 56 percent of people at each Zepbound dose, compared with 30 percent on placebo. By reaction, in the 5 mg, 10 mg and 15 mg groups versus placebo:

  • Nausea: 25, 29 and 28 percent, versus 8 percent.
  • Diarrhea: 19, 21 and 23 percent, versus 8 percent.
  • Constipation: 17, 14 and 11 percent, versus 5 percent.
  • Vomiting: 8, 11 and 13 percent, versus 2 percent.

The label says most nausea, vomiting and diarrhea occurred while the dose was being increased, and that they decreased over time. Across both trials, 4.8, 6.3 and 6.7 percent of people on 5 mg, 10 mg and 15 mg stopped treatment permanently because of adverse reactions, compared with 3.4 percent on placebo. Hair loss, injection site reactions, fatigue and dizziness also appear in the label’s table, shown in full on this page.

The boxed warning: thyroid C-cell tumors

Zepbound carries the FDA’s strongest warning. In rats, tirzepatide caused thyroid C-cell tumors. It isn’t known whether Zepbound causes these tumors, including medullary thyroid carcinoma (MTC), in people. Because of this, Zepbound is contraindicated, meaning it must not be used, in anyone with a personal or family history of MTC, or with multiple endocrine neoplasia syndrome type 2 (MEN 2). It’s also contraindicated in anyone with a known serious hypersensitivity (allergic reaction) to tirzepatide or any of its ingredients.

Other warnings on the label

The label’s warnings include severe gastrointestinal reactions, acute kidney injury from dehydration after vomiting or diarrhea, acute gallbladder disease, acute pancreatitis, serious allergic reactions, low blood sugar (with a higher risk when used with insulin or a sulfonylurea), worsening of diabetic retinopathy in people with type 2 diabetes, and pulmonary aspiration (stomach contents entering the lungs) during general anesthesia or deep sedation. Tell every clinician who treats you, including before surgery, that you take Zepbound.

Three more points from the label:

  • Pregnancy. Weight loss isn’t recommended during pregnancy, and the label says to discontinue Zepbound when a pregnancy is recognized.
  • Birth control pills. Zepbound may make oral hormonal contraceptives less effective. The label advises switching to a non-oral method or adding a barrier method for 4 weeks after starting and for 4 weeks after each dose increase.
  • Insulin and sulfonylureas. Your prescriber may need to reduce the dose of these medicines when Zepbound is started.

How do I store Zepbound?

Keep Zepbound in the refrigerator at 2°C to 8°C (36°F to 46°F), in its original carton to protect it from light. Don’t freeze it, and don’t use it if it has been frozen.

How long it can stay out of the refrigerator depends on the form:

  • Single-dose pens and single-dose vials can be kept unrefrigerated, at no more than 30°C (86°F), for up to a total of 21 days. After that, they must be thrown away.
  • An unopened KwikPen or multi-dose vial stored at room temperature (up to 30°C or 86°F) is thrown away after 30 days.
  • An opened KwikPen or multi-dose vial is thrown away after a total of 30 days at room temperature, 30 days after first use, or after 4 weekly doses, whichever comes first, even if medicine is left.

If a shipment arrives warm or a pen has been left out, your pharmacist can tell you whether it’s still within these limits.

Does insurance or Medicare cover Zepbound?

Commercial insurance and prior authorization

Coverage for weight-management drugs varies from plan to plan, even within one insurer. To find out where you stand, call the number on your insurance card and ask three things: is Zepbound on the formulary (the plan’s list of covered drugs), does it need prior authorization, and does your employer’s plan exclude weight-loss drugs altogether?

Prior authorization means your prescriber sends the plan your diagnosis and history before the plan will pay. A first denial is often a request for more information, not a final answer. The appeal letter generator drafts a prior authorization request or an appeal for your prescriber to adapt. If the plan excludes the drug entirely, compare the savings card’s not-covered price with LillyDirect self-pay before you fill, because the self-pay vial or KwikPen is cheaper at every dose.

Medicare and the GLP-1 Bridge

The Medicare Part D statute excludes drugs when they’re used for weight loss. There are two routes around that exclusion.

The Medicare GLP-1 Bridge. This is a temporary CMS program running from July 1, 2026 through December 31, 2027. If you have Part D drug coverage and you’re eligible, you pay a $50 copay for a one-month supply. For Zepbound it covers the KwikPen only, not single-dose vials or single-dose pens, and pen needles aren’t included. Eligibility depends on your BMI when you first started GLP-1 treatment and on certain conditions. People with type 2 diabetes or moderate to severe sleep apnea are directed to their Part D plan instead. Check your own case with the Bridge eligibility checker or read the Medicare GLP-1 Bridge guide.

Part D for sleep apnea. CMS names Zepbound for moderate to severe obstructive sleep apnea in adults with obesity as a use that can be covered under the basic Part D benefit, whether or not the drug is on your plan’s formulary, through the plan’s formulary exception process. Our page on whether Medicare covers Zepbound walks through both routes.

If you’re on Medicare, you can’t use the Lilly savings card. LillyDirect self-pay is still open to you as a cash purchase made outside insurance.

How Zepbound compares with other options

If Zepbound isn’t covered or you can’t tolerate it, the alternatives a prescriber may discuss include Wegovy, a weekly semaglutide injection that also comes as a daily pill, and Foundayo, a daily tablet from Lilly. Each has its own label, dose schedule and price structure. The trials behind each drug were run separately, so you can’t line up their results as a direct contest.

If you’re moving from one medicine to another, the switching planner shows what each label says about starting doses. It doesn’t convert doses between drugs, and neither should anyone but your prescriber. For eating while on treatment, the protein calculator turns published protein guidance into a daily range to discuss with your prescriber or dietitian, and the protein guidance page shows where those ranges come from.

Where these figures come from

Prices come from the manufacturer’s, the government’s or the provider’s own page, as described in how we verify prices. Label facts come from the FDA label.

Where to get Zepbound

Some links on this page are affiliate links: if you sign up through them we may earn a commission at no extra cost to you. The cheapest legitimate option is always listed first, and payouts never affect rankings. How we make money.

  1. 1. Manufacturer savings card (commercial insurance, drug covered)

    $25 per fill at 15 mg

    Single-dose pen

    Source: zepbound.lilly.comGo to the program page

  2. 2. Medicare GLP-1 Bridge

    $50 per fill at 15 mg

    KwikPen (multi-dose, 4 weekly doses)

    Source: medicare.govGo to the program page

  3. 3. LillyDirect self-pay

    $449 per fill at 15 mg

    KwikPen (multi-dose, 4 weekly doses)

    Source: lilly.comGo to the program page

  4. 4. LillyDirect self-pay

    $449 per fill at 15 mg

    Single-dose vial

    Source: lilly.comGo to the program page

  5. 5. Manufacturer savings card (commercial insurance, drug not covered)

    $449 per fill at 15 mg

    KwikPen (multi-dose, 4 weekly doses)

    Source: zepbound.lilly.comGo to the program page

Telehealth programs that prescribe Zepbound

At 15 mg, these cost more than the options above. They add an online visit with a prescriber and ongoing care.

  • Ro · $598 per fill including $149 membershipVisit Ro

Ranked by cost only. Manufacturer and government programs never pay us. To see every option for your situation, try the cheapest-path quiz.

Frequently asked questions

What is Zepbound used for?

Zepbound has two FDA-approved uses. The first is reducing excess body weight and keeping it off long term in adults with obesity, or with overweight and at least one weight-related condition. The second is treating moderate to severe obstructive sleep apnea in adults with obesity. The label says to use it with a reduced-calorie diet and increased physical activity.

How much does Zepbound cost a month?

If you pay cash through LillyDirect, vials and the KwikPen cost $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg to 15 mg when you refill within 45 days. If your commercial insurance covers it, the savings card can lower the single-dose pen to as little as $25. The list price is $1,086.37 per fill.

How does the Zepbound savings card work?

The card is for people with commercial insurance. If your plan covers Zepbound, you pay as little as $25 for a fill of the single-dose pen. If your plan doesn't cover it, a separate offer sets the single-dose pen at $499 a month. If you're on Medicare, Medicaid, TRICARE, VA or another government program, you can't use it. The card expires on 12/31/2026.

What is the difference between the Zepbound vial and the KwikPen?

A single-dose vial holds one dose, and you draw it up with a separate syringe and needle. The KwikPen is one pen that holds four weekly doses. You use it with pen needles and throw it away after the fourth dose. Both cost the same through LillyDirect at every strength. Only the KwikPen is covered by the Medicare GLP-1 Bridge.

What doses does Zepbound come in?

Zepbound comes in six strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg. The label starts everyone at 2.5 mg once weekly for four weeks, then 5 mg. After at least four weeks on the current dose, it can go up by 2.5 mg at a time. The recommended maintenance doses (the dose you stay on) for weight reduction are 5 mg, 10 mg or 15 mg, and the maximum is 15 mg once weekly.

What if I miss a dose of Zepbound?

The label says to take the missed dose as soon as possible within 4 days (96 hours) after it was due. If more than 4 days have passed, the label says to skip that dose and take the next one on your regularly scheduled day. Either way, you then go back to your usual weekly schedule. If you've missed more than one dose, ask your prescriber.

Is Zepbound approved for sleep apnea?

Yes. Zepbound is approved for moderate to severe obstructive sleep apnea in adults with obesity. For this use, the label's recommended maintenance dose is 10 mg or 15 mg once weekly. In the two 52-week sleep apnea studies on the label, body weight changed by -17.7% and -19.6% with Zepbound, versus -1.6% and -2.3% with placebo.

Does Medicare cover Zepbound?

Medicare Part D excludes drugs when they're used for weight loss, but there are two routes. The Medicare GLP-1 Bridge gives eligible Part D patients the Zepbound KwikPen for a $50 monthly copay through December 31, 2027. Separately, CMS names Zepbound for moderate to severe obstructive sleep apnea in adults with obesity as a use Part D can cover.

Do I have to stay on Zepbound to keep the weight off?

The label reports one withdrawal study. After 36 weeks on Zepbound, patients either stayed on it or were switched to placebo for 52 weeks. From week 36 to week 88, body weight rose 14.0% in those switched to placebo and fell a further 5.5% in those who stayed on Zepbound. Whether and how to continue is a decision for you and your prescriber.

Who makes Zepbound?

Eli Lilly makes Zepbound. It's Lilly's brand of tirzepatide for weight management, a prescription injection you take once a week. Lilly also makes Mounjaro, which contains the same medicine but is labeled for type 2 diabetes. Lilly sells Zepbound for self-pay through its LillyDirect pharmacy.

Sources (35)

  1. 1.
    FDA label (DailyMed): Zepbound prescribing information, section 2.4
    “Inject ZEPBOUND subcutaneously in the abdomen, thigh, or another person should inject in the back of the upper arm. Rotate injection sites with each dose.”
  2. 2.
    FDA label (DailyMed): Zepbound prescribing information, section 2.4
    “Administer ZEPBOUND once weekly at any time of day, with or without meals.”
  3. 3.
    FDA label (DailyMed): Zepbound prescribing information, section 2.4
    “Administer ZEPBOUND in combination with a reduced-calorie diet and increased physical activity.”
  4. 4.
    FDA label (DailyMed): Zepbound Medication Guide (in the prescribing information)
    “Your healthcare provider should show you how to prepare to inject your dose of ZEPBOUND before injecting the first time.”
  5. 5.
    FDA label (DailyMed): Zepbound prescribing information, section 2.4
    “Inform patients and their caregiver(s) which ZEPBOUND presentation (e.g., vial, prefilled single-dose pen, single-patient-use KwikPen) they will receive and ensure they receive training appropriate for that specific presentation. If the prescribed ZEPBOUND presentation changes, ensure patients and caregivers receive appropriate training and instruct them to consult the Instructions for Use for the newly prescribed presentation.”
  6. 6.
    FDA label (DailyMed): Zepbound prescribing information, section 2.4
    “Instruct patients using ZEPBOUND vials to use a syringe appropriate for dose administration (e.g., a 1 mL syringe capable of measuring a 0.5 mL or 0.6 mL dose) and always use a new syringe and needle for each injection.”
  7. 7.
    FDA label (DailyMed): Zepbound prescribing information, section 2.4
    “ZEPBOUND KwikPen is not recommended for self-administration by those who are visually impaired.”
  8. 8.
    FDA label (DailyMed): Zepbound prescribing information, section 16.2
    “Store ZEPBOUND single-dose pen and single-dose vial in a refrigerator at 2°C to 8°C (36°F to 46°F).”
  9. 9.
    FDA label (DailyMed): Zepbound prescribing information, section 16.2
    “If needed, each single-dose pen or single-dose vial can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days. Discard single-dose pen and single-dose vial after a total of 21 days at room temperature.”
  10. 10.
    FDA label (DailyMed): Zepbound prescribing information, section 16.2
    “Do not freeze ZEPBOUND. Do not use ZEPBOUND if frozen. Protect ZEPBOUND from heat and light. Store ZEPBOUND in the original carton to protect from light.”
  11. 11.
    FDA label (DailyMed): Zepbound prescribing information, section 16.2
    “Store unopened multi-dose vial or single-patient-use KwikPen in the refrigerator at 2°C to 8°C (36°F to 46°F). The unopened multi-dose vial or single-patient-use KwikPen can be used until the expiration date on the label if kept in the refrigerator. If stored at room temperature [up to 30°C (86°F)], throw away unopened multi-dose vial or single-patient-use KwikPen after 30 days.”
  12. 12.
    FDA label (DailyMed): Zepbound prescribing information, section 16.2
    “Throw away opened multi-dose vial or single-patient-use KwikPen after a total of 30 days at room temperature, 30 days after first use, or after taking 4 weekly doses, even if there is medicine left in it.”
  13. 13.
    FDA label (DailyMed): Zepbound Instructions for Use (in the prescribing information)
    “After 4 doses, throw away (discard) the Pen, including the unused medicine. The Pen will prevent you from dialing a full dose after you have given yourself 4 weekly doses. Do not inject the leftover medicine.”
  14. 14.
    FDA label (DailyMed): Zepbound prescribing information, section 8.1
    “Weight loss offers no benefit to a pregnant patient and may cause fetal harm. Advise pregnant patients that weight loss is not recommended during pregnancy and to discontinue ZEPBOUND when a pregnancy is recognized (see Clinical Considerations).”
  15. 15.
    FDA label (DailyMed): Zepbound prescribing information, section 8.3
    “Use of ZEPBOUND may reduce the efficacy of oral hormonal contraceptives due to delayed gastric emptying. This delay is largest after the first dose and diminishes over time. Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method, or add a barrier method of contraception for 4 weeks after initiation with ZEPBOUND and for 4 weeks after each dose escalation [see Drug Interactions (7.2) and Clinical Pharmacology (12.2, 12.3)].”
  16. 16.
    FDA label (DailyMed): Zepbound prescribing information, section 7.1
    “ZEPBOUND lowers blood glucose. When initiating ZEPBOUND, consider reducing the dose of concomitantly administered insulin or insulin secretagogues (e.g., sulfonylureas) to reduce the risk of hypoglycemia [see Warnings and Precautions (5.7)].”
  17. 17.
    FDA label (DailyMed): Zepbound prescribing information, section 14.1
    “In both trials, weight reduction was assessed after 72 weeks of treatment (at least 52 weeks at maintenance dose).”
  18. 18.
    FDA label (DailyMed): Zepbound prescribing information, section 14.1, Table 2
    “Table 2: Changes in Body Weight at Week 72 in Studies 1 and 2 in Patients with Obesity or Overweight. % Change from baseline: Study 1 Placebo N = 643: -3.1; Study 1 ZEPBOUND 5 mg N = 630: -15.0; Study 1 ZEPBOUND 10 mg N = 636: -19.5; Study 1 ZEPBOUND 15 mg N = 630: -20.9; Study 2 Placebo N = 315: -3.2; Study 2 ZEPBOUND 10 mg N = 312: -12.8; Study 2 ZEPBOUND 15 mg N = 311: -14.7”
  19. 19.
    FDA label (DailyMed): Zepbound prescribing information, section 14.2, Table 9
    “Table 9: Changes in Apnea-Hypopnea Index (AHI), Hypoxic Burden, and Body Weight at Week 52 in Study 5 and Study 6. Body weight (kg) - % change from baseline: Study 5 Placebo N = 120: -1.6; Study 5 ZEPBOUND MTD (10 mg or 15 mg) N = 114: -17.7; Study 6 Placebo N = 114: -2.3; Study 6 ZEPBOUND MTD (10 mg or 15 mg) N = 119: -19.6”
  20. 20.
    FDA label (DailyMed): Zepbound prescribing information, section 14.1, Table 6
    “Table 6: Changes in Body Weight After 36-Week Open-Label Treatment Followed by Randomized Withdrawal (Study 4) in Patients with Obesity or Overweight. % change from Week 36 at Week 88: Placebo N=335: 14.0; ZEPBOUND (MTD 10 mg or 15 mg) N=335: -5.5”
  21. 21.
    FDA label (DailyMed): Zepbound prescribing information, section 2.2
    “The recommended maintenance dosage is 5 mg, 10 mg, or 15 mg, injected subcutaneously once weekly.”
  22. 22.
    FDA label (DailyMed): Zepbound prescribing information, section 2.1
    “The 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage.”
  23. 23.
    FDA label (DailyMed): Zepbound prescribing information, section 1
    “ZEPBOUND contains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.”
  24. 24.
    FDA label (DailyMed): Zepbound prescribing information, section 5.2
    “ZEPBOUND is not recommended in patients with severe gastroparesis.”
  25. 25.
    FDA label (DailyMed): Zepbound prescribing information, section 8.4
    “The safety and effectiveness of ZEPBOUND have not been established in pediatric patients.”
  26. 26.
    FDA label (DailyMed): Zepbound prescribing information, section 4
    “ZEPBOUND is contraindicated in patients with: A personal or family history of MTC or in patients with MEN 2 [see Warnings and Precautions (5.1)].”
  27. 27.
    FDA label (DailyMed): Zepbound prescribing information, section 4
    “ZEPBOUND is contraindicated in patients with: Known serious hypersensitivity to tirzepatide or any of the excipients in ZEPBOUND.”
  28. 28.
    Federal Register: Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (proposed rule, 89 FR 99340)
    “The statutory definition of a covered Part D drug at section 1860D-2(e)(2) of the Social Security Act (the Act) excludes certain drugs and uses—specifically, those that may be excluded by Medicaid under section 1927(d)(2) of the Act. This includes, at section 1927(d)(2)(A) of the Act, “agents when used for anorexia, weight loss, or weight gain.” Historically, drugs used for weight loss have been excluded from the definition of covered Part D drug, regardless of their use for treatment of individuals with obesity, and have been an optional drug benefit for Medicaid programs.”
  29. 29.
    CMS: Information for Part D Plans
    “Beneficiaries who are prescribed an eligible GLP-1 drug for a use that is coverable under the basic Medicare Part D benefit, regardless of whether the eligible GLP-1 drug is on the Part D plan’s formulary (e.g., Zepbound® for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity; Wegovy® to reduce the risk of major adverse cardiovascular (CV) events in adults with established CV disease and either obesity or overweight) would not qualify for coverage of that eligible GLP-1 drug under the Medicare GLP-1 Bridge. Part D plan sponsors must continue to follow their existing formulary exception processes for these requests.”
  30. 30.
  31. 31.
  32. 32.
  33. 33.
  34. 34.
  35. 35.